The Development of Investigator-Initiated Clinical Trials in Surgical Oncology

被引：4
|
作者：
McDonald, Hannah G. [1 ]
Cassim, Emily B. [1 ]
Harper, Megan M. [1 ]
Burke, Erin E. [1 ]
Marcinkowski, Emily F. [1 ]
Cavnar, Michael J. [1 ]
Pandalai, Prakash K. [1 ]
Kim, Joseph [1 ,2 ]
机构：
[1] Univ Kentucky, Div Surg Oncol, 800 Rose St C224, Lexington, KY 40508 USA
[2] Univ Kentucky, Dept Surg, Div Surg Oncol, 800 Rose St, C223, Lexington, KY 40536 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 32卷 / 01期
关键词：
Investigator-initiated trials; Surgical oncology; Clinical trial protocol development; CANCER PATIENTS; LIPOSOMAL IRINOTECAN; AMERICAN SOCIETY; BARRIERS; SURGEONS; FUTURE; NIH;
D O I：
10.1016/j.soc.2022.07.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：13 / 25
页数：13
相关论文
共 50 条
  • [21] Transparency and accuracy in funding investigator-initiated clinical trials: a systematic search in clinical trials databases
    Madeira, Catarina
    Santos, Francisco
    Kubiak, Christine
    Demotes, Jacques
    Monteiro, Emilia Carreira
    BMJ OPEN, 2019, 9 (05):
  • [22] INFRASTRUCTURE DEVELOPMENT OF INVESTIGATOR-INITIATED CLINICAL TRIALS AT A FRONT-LINE REGIONAL HOSPITAL IN JAPAN
    Takeda, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 69 - 69
  • [23] Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN)
    Madeira, C.
    Pais, A.
    Kubiak, C.
    Demotes, J.
    Monteiro, E. C.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2016, 4 : 141 - 148
  • [24] International models of investigator-initiated trials: implications for Japan
    Trimble, E. L.
    Ledermann, J.
    Law, K.
    Miyata, T.
    Imamura, C. K.
    Nam, B. -H.
    Kim, Y. H.
    Bang, Y. -J.
    Michaels, M.
    Ardron, D.
    Amano, S.
    Ando, Y.
    Tominaga, T.
    Kurokawa, K.
    Takebe, N.
    ANNALS OF ONCOLOGY, 2012, 23 (12) : 3151 - 3155
  • [25] Investigator-initiated Clinical Trials for Neurological Diseases in Japan: Pipeline and Support Structures
    Sakushima, Ken
    Nakamura, Harumasa
    Fujihara, Kazuo
    NEUROTHERAPEUTICS, 2024, 21 (04)
  • [26] Mobile access to virtual randomization for investigator-initiated trials
    Deserno, Thomas M.
    Keszei, Andras P.
    CLINICAL TRIALS, 2017, 14 (04) : 396 - 405
  • [27] NIH MULTICENTER INVESTIGATOR-INITIATED TRIALS - AN ENDANGERED SPECIES
    MEINERT, CL
    CONTROLLED CLINICAL TRIALS, 1988, 9 (02): : 97 - 102
  • [28] Investigator-initiated cancer trials with INDs for approval in Japan
    Chiyo K. Imamura
    Naoko Takebe
    Seigo Nakamura
    Hideyuki Saya
    Naoto T. Ueno
    Nature Reviews Clinical Oncology, 2010, 7 : 127 - 128
  • [29] Lessons learned from investigator-initiated clinical trials for localized pancreatic cancer
    Tsai, Susan
    Evans, Douglas B.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (01) : 69 - 74
  • [30] Ohio CTSAs Implement a Reliant IRB Model for Investigator-Initiated Multicenter Clinical Trials
    Cola, Philip A.
    Reider, Carson
    Strassor, Jane E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2013, 6 (03): : 176 - 178
12345